Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$310K Sell
6,989
-3,650
-34% -$171K ﹤0.01% 849
2026
Q1
$504K Buy
10,639
+907
+9% +$46.4K ﹤0.01% 620
2025
Q4
$666K Sell
9,732
-11,467
-54% -$793K ﹤0.01% 485
2025
Q3
$1.53M Buy
21,199
+16,239
+327% +$1.25M 0.01% 289
2025
Q2
$386K Sell
4,960
-4,855
-49% -$393K ﹤0.01% 408
2025
Q1
$799K Buy
9,815
+5,568
+131% +$488K 0.02% 263
2024
Q4
$382K Sell
4,247
-2,991
-41% -$239K 0.01% 404
2024
Q3
$449K Sell
7,238
-1,436
-17% -$80.5K 0.01% 314
2024
Q2
$464K Sell
8,674
-2,793
-24% -$158K 0.01% 318
2024
Q1
$683K Buy
11,467
+2,068
+22% +$117K 0.02% 216
2023
Q4
$559K Buy
9,399
+460
+5% +$21.1K 0.02% 281
2023
Q3
$375K Buy
8,939
+765
+9% +$37.5K 0.05% 137
2023
Q2
$418K Buy
8,174
+1,985
+32% +$105K 0.08% 141
2023
Q1
$361K Sell
6,189
-3,211
-34% -$192K 0.05% 181
2022
Q4
$521K Buy
+9,400
New +$458K 0.07% 165

Other funds holding DOCU

Marex Group's DOCU Position: Q2 2026 in Review

Marex Group reduced its DocuSign (DOCU) stake by 34% in Q2 2026, selling an estimated $171K and leaving 6,989 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #849.

Marex Group first reported a position in DOCU in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.53M in Q3 2025. 674 funds tracked by Wall St. Rank hold DOCU as of Q2 2026.

  • Marex Group held 6,989 shares of DocuSign worth $310K as of Q2 2026.
  • Marex Group sold 3,650 DocuSign shares in Q2 2026, an estimated $171K.
  • DocuSign made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #849 holding.
  • Marex Group first reported a position in DocuSign in Q4 2022 and has held it in 15 quarters since.
  • Marex Group's DocuSign position peaked at $1.53M in Q3 2025.
  • 674 funds tracked by Wall St. Rank held DocuSign as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.